The activity of BV as frontline therapy in some PTCL categories needs to be further investigated, especially given the variability of CD30 expression across subtypes, with the highest levels being found in ALCL and cHL. The gene discussed is TNFRSF8; the disease is anaplastic large cell lymphoma.